$2.61 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 93 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALEC | New | ALECTOR INC | $36,634,000 | – | 1,956,923 | +100.0% | 1.40% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $15,336,000 | – | 394,737 | +100.0% | 0.59% | – |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $13,116,000 | – | 1,701,222 | +100.0% | 0.50% | – |
| SWAV | New | SHOCKWAVE MED INC | $10,448,000 | – | 312,146 | +100.0% | 0.40% | – |
| PTCT | New | PTC THERAPEUTICS INC | $8,921,000 | – | 237,000 | +100.0% | 0.34% | – |
| New | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $4,647,000 | – | 5,000,000 | +100.0% | 0.18% | – | |
| AGLE | New | AEGLEA BIOTHERAPEUTICS INC | $4,025,000 | – | 500,046 | +100.0% | 0.15% | – |
| ITMR | New | ITAMAR MED LTDsponsored ads | $3,647,000 | – | 314,136 | +100.0% | 0.14% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $2,699,000 | – | 285,000 | +100.0% | 0.10% | – |
| MNLO | New | MENLO THERAPEUTICS INC | $1,558,000 | – | 198,451 | +100.0% | 0.06% | – |
| MLNTQ | New | MELINTA THERAPEUTICS INC | $1,267,000 | – | 356,952 | +100.0% | 0.05% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $406,000 | – | 226,802 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.